Brain development in infantile-onset pompe disease treated by enzyme replacement therapy

Pediatric Research

Volumn 60, Issue 3, 2006, Pages 349-352

  Chien, Yin Hsiu ^a   Lee, Ni Chung ^a   Peng, Shinn Forng ^a   Hwu, Wuh Liang ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATINE; GLUCAN 1,4 ALPHA GLUCOSIDASE; GLYCOGEN; INOSITOL; N ACETYLASPARTIC ACID; RECOMBINANT ENZYME; RECOMBINANT GLUCAN 1,4 ALPHA GLUCOSIDASE; UNCLASSIFIED DRUG;

ARTICLE; BRAIN DEVELOPMENT; CAPSULA INTERNA; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS CALLOSUM; ENZYME REPLACEMENT; FEMALE; FOLLOW UP; GLYCOGEN STORAGE DISEASE TYPE 2; HUMAN; HUMAN CELL; INFANT; INFANT DISEASE; MALE; MYELINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ONSET AGE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SKIN FIBROBLAST; WHITE MATTER;

BRAIN; CHILD, PRESCHOOL; FEMALE; GLUCAN 1,4-ALPHA-GLUCOSIDASE; GLYCOGEN STORAGE DISEASE TYPE II; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE;

EID: 33747609102     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.pdr.0000233014.84318.4e     Document Type: Article

References (18)

1. Hirschhorn R 2001 Glycogen storage disease type II: acid-glucosidase (acid maltase) deficiency. In Scriver CS, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 3389-3420
2. Gambetti P, DiMauro S, Baker L 1971 Nervous system in Pompe's disease. Ultrastructure and biochemistry. J Neuropathol Exp Neurol 30:412-430
3. Sakurai I, Tosaka A, Mori Y, Imura S, Aoki K 1974 Glycogenosis type II (Pompe). The fourth autopsy case in Japan. Acta Pathol Jpn 24:829-846
4. van den Hout HM, Hop W, van Diggelen OP, Smeitink JA, Smit GP, Poll-The BT, Bakker HD, Loonen MC, de Klerk JB, Reuser AJ, van der Ploeg AT 2003 The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature. Pediatrics 112:332-340
5. Chen YT, Amalfitano A 2000 Towards a molecular therapy for glycogen storage disease type II (Pompe disease). Mol Med Today 6:245-251
6. Van den Hout H, Reuser AJ, Vulto AG, Loonen MC, Cromme-Dijkhuis A, Van der Ploeg AT 2000 Recombinant human alpha-glucosidase from rabbit milk in Pompe patients. Lancet 356:397-398
7. Van den Hout JM, Reuser AJ, de Klerk JB, Arts WF, Smeitink JA, Van der Ploeg AT 2001 Enzyme therapy for pompe disease with recombinant human alpha-glucosidase from rabbit milk. J Inherit Metab Dis 24:266-274
8. Chien YH, Peng SF, Wang TR, Hwu WL 2002 Cranial MR spectroscopy of tetrahydrobiopterin deficiency. AJNR Am J Neuroradiol 23:1055-1058
9. Barkovich AJ, Kjos BO, Jackson DE Jr, Norman D 1988 Normal maturation of the neonatal and infant brain: MR imaging at 1.5 T. Radiology 166:173-180
10. Barkovich AJ, Kjos BO 1988 Normal postnatal development of the corpus callosum as demonstrated by MR imaging. AJNR Am J Neuroradiol 9:487-491
11. Hashimoto T, Tayama M, Miyazaki M, Fujii E, Harada M, Miyoshi H, Tanouchi M, Kuroda Y 1995 Developmental brain changes investigated with proton magnetic resonance spectroscopy. Dev Med Child Neurol 37:398-405
12. Zimmerman RA, Wang ZJ 1997 The value of proton MR spectroscopy in pediatric metabolic brain disease. AJNR Am J Neuroradiol 18:1872-1879
13. Chen CP, Lin SP, Tzen CY, Tsai FJ, Hwu WL, Wang W 2004 Detection of a homozygous D645E mutation of the acid alpha-glucosidase gene and glycogen deposition in tissues in a second-trimester fetus with infantile glycogen storage disease type II. Prenat Diagn 24:231-232
14. Araoz C, Sun CN, Shenefelt R, White HJ 1974 Glycogenosis type II (Pompe's disease): ultrastructure of peripheral nerves. Neurology 24:739-742
15. Yamada H, Sadato N, Konishi Y, Muramoto S, Kimura K, Tanaka M, Yonekura Y, Ishii Y, Itoh H 2000 A milestone for normal development of the infantile brain detected by functional MRI. Neurology 55:218-223
16. Lee CC, Chen CY, Chou TY, Chen FH, Lee CC, Zimmerman RA 1996 Cerebral MR manifestations of Pompe disease in an infant. AJNR Am J Neuroradiol 17:321-322
17. Kondo A, Sato Y, Nagara H 1991 An ultrastructural study of oligodendrocytes in Zitter rat: a new animal model for hypomyelination in the CNS. J Neurocytol 20:929-939
18. Jardim L, Vedolin L, Schwartz IV, Burin MG, Cecchin C, Kalakun L, Matte U, Aesse F, Pitta-Pinheiro C, Marconato J, Giugliani R 2004 CNS involvement in Fabry disease: clinical and imaging studies before and after 12 months of enzyme replacement therapy. J Inherit Metab Dis 27:229-240